- Seen in children and young adults (typically diagnosed at 1–15 years; incidence 1:3,000 live births, equal sex distribution) presenting with cafe-au-lait macules, axillary/inguinal freckling (Crowe sign), subcutaneous neurofibromas, progressive visual loss, proptosis, or macrocephaly.
- Caused by autosomal dominant mutation of the NF1 tumor suppressor gene on chromosome 17q11.2 (encoding neurofibromin), causing hyperactive RAS signaling and multiple neural crest-derived tumors.
Imaging Findings
- Brain & Orbit MRI (Standard Diagnostic Protocol):
- –Optic Pathway Glioma (OPG - 15–20% of NF1): Fusiform enlargement and T2/FLAIR hyperintensity of the intraorbital, canalicular, or chiasmatic optic nerves with variable enhancement; classic downward kinking of the intraorbital optic nerve.
- –FASI / UBOs (Foci of Abnormal Signal Intensity / Unidentified Bright Objects): Non-mass-like patches of T2/FLAIR hyperintensity without mass effect or enhancement, classically located in the globus pallidus, thalamus, brainstem, and cerebellar white matter; spontaneously regress in adulthood.
- –DWI / ADC: Benign FASI / UBOs and low-grade Optic Pathway Gliomas show no diffusion restriction (facilitated diffusion with high ADC values); new focal diffusion restriction (low ADC) within a plexiform neurofibroma or glioma is a high-yield red flag for malignant transformation (MPNST or high-grade glioma).
- –SWI / T2 GRE: Typically shows no blooming artifact in uncomplicated UBOs or low-grade optic pathway gliomas, helping distinguish them from hemorrhagic or calcified lesions.
- Sphenoid Wing Dysplasia (Pathognomonic Skeletal Hallmark):
- –Absence or hypoplasia of the greater wing of the sphenoid bone on CT/MRI, leading to herniation of the temporal lobe into the orbit causing pulsatile proptosis.
- Plexiform Neurofibromas ('Bag of Worms'):
- –Infiltrative, multinodular soft-tissue masses tracking along major nerve plexuses (brachial, lumbosacral, cranial) with classic 'target sign' on T2WI (central low-signal collagenous stroma surrounded by high-signal myxoid rim); carries 10% lifetime risk of malignant transformation into Malignant Peripheral Nerve Sheath Tumor (MPNST).
- Plain Radiograph (X-Ray) Findings:
- –Skull X-Ray ('Bare Orbit Sign'): Absence of the innominate line and greater wing of the sphenoid bone producing a unilateral radiolucent, enlarged orbit.
- –Spine & Skeletal X-Ray: Sharp short-segment thoracic kyphoscoliosis, posterior vertebral body scalloping (from dural ectasia), 'ribbon ribs' (twisted, attenuated ribs), and anterolateral bowing of the tibia with congenital pseudoarthrosis.
Differential Diagnosis
| Differential Diagnosis | Key Distinguishing Features |
|---|---|
Neurofibromatosis Type 2 (NF2) | Bilateral vestibular schwannomas (MISME: Multiple Inherited Schwannomas, Meningiomas, Ependymomas); lacks optic pathway gliomas, sphenoid wing dysplasia, or UBOs; NF2 gene on chromosome 22q12. |
Tuberous Sclerosis Complex (TSC) | Subependymal nodules (candle guttering), subependymal giant cell astrocytoma (SEGA at foramen of Monro), cortical tubers, and transmantle radial migration lines; renal angiomyolipomas and cardiac rhabdomyomas. |
Optic Nerve Sheath Meningioma | Tubular eccentric or circumferential thickening of the optic nerve sheath producing the classic 'tram-track sign' (non-enhancing optic nerve surrounded by avidly enhancing sheath); middle-aged females; calcification common on CT. |
Idiopathic Optic Neuritis | Acute painful visual loss in young adults; short-segment intense enhancement and swelling of the optic nerve without fusiform mass-like enlargement; strong association with Multiple Sclerosis. |
Important Points to Remember
- Diagnostic Pitfall: Mistaking harmless transient UBOs (FASI) in the basal ganglia or cerebellum for low-grade astrocytomas! Remember: UBOs show zero mass effect, zero vasogenic edema, and zero contrast enhancement. If a lesion exhibits expansile mass effect, progressive contrast enhancement, or surrounding edema, suspect a true neoplastic astrocytoma.
- Crucial Review Areas:
- 1.Greater wing of sphenoid on bone windows for sphenoid wing dysplasia and temporal lobe herniation.
- 2.Optic chiasm and retrochiasmatic optic tracts (chiasmatic/tract involvement carries higher visual morbidity than isolated pre-chiasmatic optic nerve disease).
- 3.Thoracic and lumbosacral spine for plexiform neurofibromas and dural ectasia with posterior vertebral body scalloping.
- 4.Plexiform neurofibromas for rapid growth, loss of central T2 target sign, or heterogeneous necrosis (signals malignant degeneration to MPNST).
- Case-Specific Radiologist Management:
- 1.Immediate Verbal Alert: Direct telephone notification to pediatric neuro-oncology or ophthalmology if acute optic chiasm compression, progressive visual deterioration, or malignant degeneration of a plexiform mass is suspected.
- 2.Dedicated Neuro-Ophthalmic MRI Protocol: Protocol high-resolution contrast-enhanced thin-slice (1.5–2 mm) coronal and axial orbit MRI (fat-suppressed T2 and fat-suppressed post-contrast T1) to map anterior optic nerve and posterior chiasm/tract extent.
- 3.Whole-Body MRI / FDG-PET/CT for MPNST Surveillance: For large symptomatic plexiform neurofibromas undergoing rapid enlargement or new intractable pain, recommend 18F-FDG PET/CT or diffusion-weighted whole-body MRI (SUVmax >3.5 indicates high-risk malignant transformation to MPNST).
- 4.Non-Invasive Vascular Screening (MRA/CTA): Screen for NF1 vasculopathy (moyamoya syndrome, renal artery stenosis causing severe pediatric hypertension).
- 5.Specialist Neurofibromatosis MDT: Present to the comprehensive Neurofibromatosis Multidisciplinary Team for coordination of MEK-inhibitor biological therapy (Selumetinib for inoperable plexiform neurofibromas) and visual field surveillance.